{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T04:29:47Z","timestamp":1794284987596,"version":"4.9.0"},"reference-count":119,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"45","license":[{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,11,11]]},"abstract":"<jats:p>The gastrointestinal tract (GI) is the second most affected organ system in individuals suffering from systemic\/localized scleroderma (SSc) or localized scleroderma. SSc can affect any part of the GI, between the oral cavity and anorectum. The annual incidence of SSc in the United States is estimated to be 19.3 cases per million adults, with the highest incidence reported in people aged 44 to 55. Females are 5 times more likely than males to suffer from SSc. Morbidity and mortality rates associated with SSc are predominantly elevated among patients with GI manifestations. Esophageal and intestinal manifestations impact 90% and 40% to 70% of patients with systemic scleroderma, respectively. SSc patients are known to suffer from small bowel hypomotility and small intestinal bacterial overgrowth, which cause malabsorption and malnutrition, ultimately contributing to the 50% mortality rate. Fecal incontinence is a common symptom of SSc that can lead to depression. SSc patients may suffer from gastrointestinal complications that can negatively impact their quality of life on a daily basis. Multidisciplinary approaches are necessary for systematically managing gastrointestinal complications associated with SSc. A prospective study should focus on developing targeted therapies to improve recovery patterns and prognosis in cases of SSc. This article summarizes the epidemiology, commonly reported clinical manifestations, complications, and available treatments for treating GI pathology in SSc patients.<\/jats:p>","DOI":"10.1097\/md.0000000000031780","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T09:10:33Z","timestamp":1668676233000},"page":"e31780","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":66,"title":["Gastrointestinal involvement in systemic sclerosis: An updated review"],"prefix":"10.1097","volume":"101","author":[{"given":"Mahmoud","family":"Nassar","sequence":"first","affiliation":[{"name":"Department of Medicine, Icahn School of Medicine at Mount Sinai, NYC Health+Hospitals, Queens, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Ghernautan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Icahn School of Medicine at Mount Sinai, NYC Health+Hospitals, Queens, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nso","family":"Nso","sequence":"additional","affiliation":[{"name":"Department of Medicine, Icahn School of Medicine at Mount Sinai, NYC Health+Hospitals, Queens, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akwe","family":"Nyabera","sequence":"additional","affiliation":[{"name":"Department of Medicine, Icahn School of Medicine at Mount Sinai, NYC Health+Hospitals, Queens, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Cuevas","family":"Castillo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Icahn School of Medicine at Mount Sinai, NYC Health+Hospitals, Queens, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan","family":"Tu","sequence":"additional","affiliation":[{"name":"Department of Medicine, Icahn School of Medicine at Mount Sinai, NYC Health+Hospitals, Queens, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Medina","sequence":"additional","affiliation":[{"name":"Department of Medicine, Icahn School of Medicine at Mount Sinai, NYC Health+Hospitals, Queens, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camelia","family":"Ciobanu","sequence":"additional","affiliation":[{"name":"Internal Medicine, Saint Barnabas Hospital, Bronx, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Alfishawy","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Faculty of Medicine, Cairo University, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Rizzo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Icahn School of Medicine at Mount Sinai, NYC Health+Hospitals, Queens, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saphwat","family":"Eskaros","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, NYC Health+Hospitals, Queens, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamdouh","family":"Mahdi","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Faculty of Medicine, Helwan University, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Khalifa","sequence":"additional","affiliation":[{"name":"Hospital Management Department, Helwan University, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3396-6894","authenticated-orcid":false,"given":"Mohamed","family":"El-Kassas","sequence":"additional","affiliation":[{"name":"Endemic Medicine Department, Faculty of Medicine, Helwan University, Cairo, Egypt."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.clnu.2012.06.005","article-title":"Nutritional status and gastrointestinal symptoms in systemic sclerosis patients","volume":"32","author":"Murtaugh","year":"2013","journal-title":"Clin Nutr"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-230X-8-7","article-title":"Gastrointestinal symptoms and motility disorders in patients with systemic scleroderma","volume":"8","author":"Di Ciaula","year":"2008","journal-title":"BMC Gastroenterol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1093\/rheumatology\/keq147","article-title":"Assessment of gastrointestinal symptoms in patients with systemic sclerosis in a UK tertiary referral centre","volume":"49","author":"Thoua","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U","article-title":"Severe organ involvement in systemic sclerosis with diffuse scleroderma","volume":"43","author":"Steen","year":"2000","journal-title":"Arthritis Rheum"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s13643-015-0176-2","article-title":"Factors associated with development of gastrointestinal problems in patients with scleroderma: a systematic review","volume":"4","author":"Hong","year":"2015","journal-title":"Syst Rev"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"e0163894","DOI":"10.1371\/journal.pone.0163894","article-title":"Incidences and risk factors of organ manifestations in the early course of systemic sclerosis: a longitudinal EUSTAR study","volume":"11","author":"Jaeger","year":"2016","journal-title":"PLoS One"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/BOR.0000000000000645","article-title":"Gastrointestinal involvement in systemic sclerosis: an update","volume":"31","author":"McMahan","year":"2019","journal-title":"Curr Opin Rheumatol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1136\/annrheumdis-2017-211448","article-title":"Mapping and predicting mortality from systemic sclerosis","volume":"76","author":"Elhai","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s13075-019-2078-5","article-title":"High risk of gastrointestinal hemorrhage in patients with systemic sclerosis","volume":"21","author":"Lin","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1007\/s00296-011-1988-6","article-title":"Profile of gastrointestinal involvement in patients with systemic sclerosis","volume":"32","author":"Schmeiser","year":"2012","journal-title":"Rheumatol Int"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10067-019-04810-z","article-title":"Prevalence of malnutrition in systemic sclerosis patients assessed by different diagnostic tools","volume":"39","author":"Wojteczek","year":"2020","journal-title":"Clin Rheumatol"},{"key":"R13-20250504","first-page":"11","article-title":"The relationship between autonomic dysfunction of the gastrointestinal tract and emotional distress in patients with systemic sclerosis","volume":"27","author":"DiRenzo","year":"2021","journal-title":"JCR"},{"key":"R14-20250504","first-page":"165","article-title":"Evaluation and management of esophageal manifestations in systemic sclerosis","volume":"31","author":"Denaxas","year":"2018","journal-title":"Ann Gastroenterol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/rheumatology\/kev393","article-title":"Intestinal pseudo-obstruction in patients with systemic sclerosis: an analysis of the Nationwide Inpatient Sample","volume":"55","author":"Valenzuela","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF02229706","article-title":"Colon involvement in systemic sclerosis: clinical-radiological correlations","volume":"15","author":"Govoni","year":"1996","journal-title":"Clin Rheumatol"},{"key":"R17-20250504","first-page":"e11553","article-title":"Differentiating delayed esophageal clearance from reflux in scleroderma","volume":"12","author":"Pasumarthi","year":"2020","journal-title":"Cureus"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/idh.12024","article-title":"Factors associated with gingival inflammation among adults with systemic sclerosis","volume":"12","author":"Yuen","year":"2014","journal-title":"Int J Dent Hyg"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/rheumatology\/ker153","article-title":"Internal anal sphincter atrophy in patients with systemic sclerosis","volume":"50","author":"Thoua","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/2397198319891282","article-title":"Gastrointestinal involvement in systemic sclerosis: Effects on morbidity and mortality and new therapeutic approaches","volume":"6","author":"Hoffmann-Vold","year":"2021","journal-title":"J Scleroderma Relat Disord"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1080\/1744666X.2019.1614915","article-title":"Pathophysiology of systemic sclerosis: current understanding and new insights","volume":"15","author":"Cutolo","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"R23-20250504","first-page":"208","article-title":"Scleroderma with an update about clinico-pathological correlation","volume":"153","author":"Rongioletti","year":"2018","journal-title":"G Ital Dermatol Venereol"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/apt.13963","article-title":"Review article: pathogenesis and clinical manifestations of gastrointestinal involvement in systemic sclerosis","volume":"45","author":"Kumar","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1051\/medsci\/20163202012","article-title":"[Pathophysiology of systemic sclerosis]","volume":"32","author":"Allanore","year":"2016","journal-title":"Med Sci (Paris)"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"55","DOI":"10.7861\/clinmedicine.16-1-55","article-title":"Advances in pathogenesis and treatment of systemic sclerosis","volume":"16","author":"Denton","year":"2016","journal-title":"Clin Med (Lond)"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.patbio.2015.03.003","article-title":"Cellular and molecular mechanisms in the pathophysiology of systemic sclerosis","volume":"63","author":"Hua-Huy","year":"2015","journal-title":"Pathol Biol (Paris)"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"15002","DOI":"10.1038\/nrdp.2015.2","article-title":"Systemic sclerosis","volume":"1","author":"Allanore","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1146\/annurev-pathol-011110-130312","article-title":"The pathogenesis of systemic sclerosis","volume":"6","author":"Katsumoto","year":"2011","journal-title":"Annu Rev Pathol"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.trsl.2019.02.010","article-title":"Evolving insights into the cellular and molecular pathogenesis of fibrosis in systemic sclerosis","volume":"209","author":"Korman","year":"2019","journal-title":"Transl Res"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1002\/art.21922","article-title":"Systemic sclerosis-associated Sjogren\u2019s syndrome and relationship to the limited cutaneous subtype: results of a prospective study of sicca syndrome in 133 consecutive patients","volume":"54","author":"Avouac","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/ard.2010.144782","article-title":"Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjogren\u2019s syndrome","volume":"70","author":"Theander","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0030-4220(88)90161-2","article-title":"Analysis of the oral manifestations of systemic sclerosis (scleroderma)","volume":"65","author":"Wood","year":"1988","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3390\/ijms17071189","article-title":"Orofacial manifestations and temporomandibular disorders of systemic scleroderma: an observational study","volume":"17","author":"Crincoli","year":"2016","journal-title":"Int J Mol Sci"},{"key":"R35-20250504","first-page":"1","article-title":"Reciprocal effects of scleroderma and temporomandibular dysfunction between patient cohorts","author":"Pellicano","year":"2021","journal-title":"CRANIO\u00ae"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1006\/clim.2001.5128","article-title":"Use of muscarinic agonists in the treatment of Sjogren\u2019s syndrome","volume":"101","author":"Fox","year":"2001","journal-title":"Clin Immunol"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archinte.159.2.174","article-title":"Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjogren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group","volume":"159","author":"Vivino","year":"1999","journal-title":"Arch Intern Med"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10067-007-0723-x","article-title":"The efficacy of cevimeline hydrochloride in the treatment of xerostomia in Sjogren\u2019s syndrome in southern Chinese patients: a randomised double-blind, placebo-controlled crossover study","volume":"27","author":"Leung","year":"2008","journal-title":"Clin Rheumatol"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.gcb.2009.01.014","article-title":"Esophageal dysmotility in scleroderma: a prospective study of 183 cases","volume":"33","author":"Lahcene","year":"2009","journal-title":"Gastroenterol Clin Biol"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/jgh3.12138","article-title":"Esophageal manometry, esophagogastroduodenoscopy, and duodenal mucosal histopathology in systemic sclerosis","volume":"3","author":"Adarsh","year":"2019","journal-title":"JGH Open"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1590\/1806-9282.66.1.48","article-title":"Esophageal manometry in systemic sclerosis: findings and association with clinical manifestations","volume":"66","author":"Markus","year":"2020","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s10067-018-4026-1","article-title":"Esophageal high-resolution impedance manometry alterations in asymptomatic patients with systemic sclerosis: prevalence, associations with disease features, and prognostic value","volume":"37","author":"Vettori","year":"2018","journal-title":"Clin Rheumatol"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10067-019-04794-w","article-title":"The role of high-resolution manometry in the assessment of upper gastrointestinal involvement in systemic sclerosis: a systematic review","volume":"39","author":"Schutyser","year":"2020","journal-title":"Clin Rheumatol"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jss.2014.03.025","article-title":"Usefulness of pH monitoring in predicting the survival status of patients with scleroderma awaiting lung transplantation","volume":"189","author":"Fisichella","year":"2014","journal-title":"J Surg Res"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00296-010-1595-y","article-title":"Early endoscopy in systemic sclerosis without gastrointestinal symptoms","volume":"32","author":"Thonhofer","year":"2012","journal-title":"Rheumatol Int"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"1756284819877788","DOI":"10.1177\/1756284819877788","article-title":"Lifestyle intervention for gastroesophageal reflux disease: a national multicenter survey of lifestyle factor effects on gastroesophageal reflux disease in China","volume":"12","author":"Yuan","year":"2019","journal-title":"Therap Adv Gastroenterol"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.semarthrit.2006.08.002","article-title":"Esophageal involvement in scleroderma: gastroesophageal reflux, the common problem","volume":"36","author":"Ntoumazios","year":"2006","journal-title":"Semin Arthritis Rheum"},{"key":"R48-20250504","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3109\/00365528609011120","article-title":"Long-term ranitidine in progressive systemic sclerosis (scleroderma) with gastroesophageal reflux","volume":"21","author":"Hendel","year":"1986","journal-title":"Scand J Gastroenterol"},{"key":"R49-20250504","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1442-2050.2005.00518.x","article-title":"Histamine-2 receptor antagonists at night improve gastroesophageal reflux disease symptoms for patients on proton pump inhibitor therapy","volume":"18","author":"Rackoff","year":"2005","journal-title":"Dis Esophagus"},{"key":"R50-20250504","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41598-020-57636-0","article-title":"Prevalence and predictors of proton pump inhibitor partial response in gastroesophageal reflux disease in systemic sclerosis: a prospective study","volume":"10","author":"Foocharoen","year":"2020","journal-title":"Sci Rep"},{"key":"R51-20250504","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/rheumatology\/kew216","article-title":"Effectiveness of add-on therapy with domperidone vs alginic acid in proton pump inhibitor partial response gastro-oesophageal reflux disease in systemic sclerosis: randomized placebo-controlled trial","volume":"56","author":"Foocharoen","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"R52-20250504","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1001\/archinte.1987.00370090075014","article-title":"Metoclopramide response in patients with progressive systemic sclerosis. Effect on esophageal and gastric motility abnormalities","volume":"147","author":"Johnson","year":"1987","journal-title":"Arch Intern Med"},{"key":"R53-20250504","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0016-5107(03)02380-0","article-title":"Endoscopic ablative therapy for Barrett\u2019s esophagus: current status","volume":"59","author":"Sampliner","year":"2004","journal-title":"Gastrointest Endosc"},{"key":"R54-20250504","doi-asserted-by":"crossref","first-page":"e13617","DOI":"10.1111\/nmo.13617","article-title":"Gastroparesis, metoclopramide, and tardive dyskinesia: Risk revisited","volume":"31","author":"Al-Saffar","year":"2019","journal-title":"Neurogastroenterol Motil"},{"key":"R55-20250504","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1007\/s10620-017-4679-7","article-title":"Gastroparesis: Medical and Therapeutic Advances","volume":"62","author":"Navas","year":"2017","journal-title":"Dig Dis Sci"},{"key":"R56-20250504","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.gtc.2014.11.008","article-title":"Prokinetics in gastroparesis","volume":"44","author":"Acosta","year":"2015","journal-title":"Gastroenterol Clin North Am"},{"key":"R57-20250504","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.3748\/wjg.v26.i19.2333","article-title":"Gastroparesis: new insights into an old disease","volume":"26","author":"Usai-Satta","year":"2020","journal-title":"World J Gastroenterol"},{"key":"R58-20250504","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s11605-011-1607-6","article-title":"Laparoscopic and endoscopic pyloroplasty for gastroparesis results in sustained symptom improvement","volume":"15","author":"Hibbard","year":"2011","journal-title":"J Gastrointest Surg"},{"key":"R59-20250504","first-page":"1","article-title":"Gastric electrical stimulation: an evidence-based analysis","volume":"6","author":"Medical Advisory","year":"2006","journal-title":"Ont Health Technol Assess Ser"},{"key":"R60-20250504","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2036.2008.03739.x","article-title":"Watermelon stomach in systemic sclerosis: its incidence and management","volume":"28","author":"Marie","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"R61-20250504","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.gie.2013.04.173","article-title":"Radiofrequency ablation for refractory gastric antral vascular ectasia (with video)","volume":"78","author":"McGorisk","year":"2013","journal-title":"Gastrointest Endosc"},{"key":"R62-20250504","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/BF01297028","article-title":"Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility","volume":"36","author":"Abell","year":"1991","journal-title":"Dig Dis Sci"},{"key":"R63-20250504","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/s10620-018-4977-8","article-title":"Intestinal Involvement in Systemic Sclerosis: a clinical review","volume":"63","author":"Sakkas","year":"2018","journal-title":"Dig Dis Sci"},{"key":"R64-20250504","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/RHU.0b013e3180645d2a","article-title":"Treatment of small intestinal disease in systemic sclerosis with octreotide: a prospective study in 7 patients","volume":"13","author":"Nikou","year":"2007","journal-title":"J Clin Rheumatol"},{"key":"R65-20250504","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/ajg.2017.46","article-title":"Hydrogen and methane-based breath testing in gastrointestinal disorders: the North American consensus","volume":"112","author":"Rezaie","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"R66-20250504","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.3748\/wjg.v16.i24.2978","article-title":"Small intestinal bacterial overgrowth syndrome","volume":"16","author":"Bures","year":"2010","journal-title":"World J Gastroenterol"},{"key":"R67-20250504","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1007\/s10620-007-0065-1","article-title":"A systematic review of diagnostic tests for small intestinal bacterial overgrowth","volume":"53","author":"Khoshini","year":"2008","journal-title":"Dig Dis Sci"},{"key":"R68-20250504","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1093\/rheumatology\/key175","article-title":"Treatment of small intestinal bacterial overgrowth in systemic sclerosis: a systematic review","volume":"57","author":"Pittman","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"R69-20250504","first-page":"111","article-title":"Antibiotic therapy in small intestinal bacterial overgrowth: rifaximin versus metronidazole","volume":"13","author":"Lauritano","year":"2009","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R70-20250504","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.3748\/wjg.15.2628","article-title":"Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: experience with Rifaximin","volume":"15","author":"Peralta","year":"2009","journal-title":"World J Gastroenterol"},{"key":"R71-20250504","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/MEG.0000000000000557","article-title":"A proof-of-concept study showing antibiotics to be more effective in irritable bowel syndrome with than without small-intestinal bacterial overgrowth: a randomized, double-blind, placebo-controlled trial","volume":"28","author":"Ghoshal","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R72-20250504","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11894-015-0482-9","article-title":"How to test and treat small intestinal bacterial overgrowth: an evidence-based approach","volume":"18","author":"Rezaie","year":"2016","journal-title":"Curr Gastroenterol Rep"},{"key":"R73-20250504","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/rheumatology\/kep226","article-title":"Small intestinal bacterial overgrowth in systemic sclerosis","volume":"48","author":"Marie","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"R74-20250504","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/MCG.0000000000000814","article-title":"Probiotics for preventing and treating small intestinal bacterial overgrowth: a meta-analysis and systematic review of current evidence","volume":"51","author":"Zhong","year":"2017","journal-title":"J Clin Gastroenterol"},{"key":"R75-20250504","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/ajg.2017.230","article-title":"Low-dose linaclotide (72 mug) for chronic idiopathic constipation: a 12-week, randomized, double-blind, placebo-controlled trial","volume":"113","author":"Schoenfeld","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"R76-20250504","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1056\/NEJMoa1010863","article-title":"Two randomized trials of linaclotide for chronic constipation","volume":"365","author":"Lembo","year":"2011","journal-title":"N Engl J Med"},{"key":"R77-20250504","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/j.1365-2036.2007.03320.x","article-title":"Lubiprostone, a locally acting chloride channel activator, in adult patients with chronic constipation: a double-blind, placebo-controlled, dose-ranging study to evaluate efficacy and safety","volume":"25","author":"Johanson","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"R78-20250504","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/ajg.2015.115","article-title":"A randomized, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy, safety, and tolerability of prucalopride in men with chronic constipation","volume":"110","author":"Yiannakou","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"R79-20250504","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11894-019-0699-0","article-title":"Colonic and anorectal manifestations of systemic sclerosis","volume":"21","author":"Sattar","year":"2019","journal-title":"Curr Gastroenterol Rep"},{"key":"R80-20250504","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/BOR.0000000000000545","article-title":"Gastrointestinal involvement in systemic sclerosis: diagnosis and management","volume":"30","author":"McMahan","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"R81-20250504","doi-asserted-by":"crossref","first-page":"992","DOI":"10.3899\/jrheum.110826","article-title":"Effect of gastrointestinal manifestations on quality of life in 87 consecutive patients with systemic sclerosis","volume":"39","author":"Omair","year":"2012","journal-title":"J Rheumatol"},{"key":"R82-20250504","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/003655299750026434","article-title":"Bowel problems in patients with systemic sclerosis","volume":"34","author":"Trezza","year":"1999","journal-title":"Scand J Gastroenterol"},{"key":"R83-20250504","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3109\/03009742.2011.579575","article-title":"Faecal incontinence in patients with systemic sclerosis: is an impaired internal anal sphincter the only cause?","volume":"40","author":"Fynne","year":"2011","journal-title":"Scand J Rheumatol"},{"key":"R84-20250504","first-page":"581","article-title":"Clinical correlates of faecal incontinence in systemic sclerosis: identifying therapeutic avenues","volume":"56","author":"Richard","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"R85-20250504","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.rdc.2017.09.002","article-title":"Gastrointestinal and hepatic disease in systemic sclerosis","volume":"44","author":"Frech","year":"2018","journal-title":"Rheum Dis Clin North Am"},{"key":"R86-20250504","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1080\/00365521.2016.1218537","article-title":"Efficacy of anorectal biofeedback in scleroderma patients with fecal incontinence: a case-control study","volume":"51","author":"Collins","year":"2016","journal-title":"Scand J Gastroenterol"},{"key":"R87-20250504","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/gut.51.6.881","article-title":"Sacral nerve stimulation for faecal incontinence due to systemic sclerosis","volume":"51","author":"Kenefick","year":"2002","journal-title":"Gut"},{"key":"R88-20250504","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.rdc.2015.04.007","article-title":"Systemic sclerosis: gastrointestinal disease and its management","volume":"41","author":"Gyger","year":"2015","journal-title":"Rheum Dis Clin North Am"},{"key":"R90-20250504","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","article-title":"Update of EULAR recommendations for the treatment of systemic sclerosis","volume":"76","author":"Kowal-Bielecka","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R91-20250504","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/00365521.2020.1761997","article-title":"G-POEM may be an optional treatment for refractory gastroparesis in systemic sclerosis","volume":"55","author":"Gonzalez","year":"2020","journal-title":"Scand J Gastroenterol"},{"key":"R92-20250504","first-page":"S22","article-title":"Probiotics for the treatment of systemic sclerosis-associated gastrointestinal bloating\/distention","volume":"29","author":"Frech","year":"2011","journal-title":"Clin Experimental Rheumatol Incl Suppl"},{"key":"R93-20250504","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s12016-020-08831-4","article-title":"Clinical treatment options in scleroderma: recommendations and comprehensive review","volume":"62","author":"Zhao","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"key":"R95-20250504","doi-asserted-by":"crossref","first-page":"247","DOI":"10.5301\/jsrd.5000214","article-title":"Gastrointestinal manifestations of systemic sclerosis","volume":"1","author":"Shreiner","year":"2016","journal-title":"J Scleroderma Relat Disord"},{"key":"R96-20250504","first-page":"35","article-title":"Nutritional implications of GI-related scleroderma","volume":"40","author":"Chatterjee","year":"2016","journal-title":"Pract Gastroenterol"},{"key":"R97-20250504","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/RHU.0000000000000626","article-title":"Gastrointestinal involvement in systemic sclerosis: an update","volume":"24","author":"Miller","year":"2018","journal-title":"J Clin Rheumatol"},{"key":"R98-20250504","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4172\/2161-1149.1000235","article-title":"Gastrointestinal manifestations of systemic sclerosis","volume":"8","author":"McFarlane","year":"2018","journal-title":"Rheumatology (Sunnyvale)"},{"key":"R99-20250504","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12876-015-0241-2","article-title":"Assessment of esophageal involvement in systemic sclerosis and morphea (localized scleroderma) by clinical, endoscopic, manometric and pH metric features: a prospective comparative hospital based study","volume":"15","author":"Arif","year":"2015","journal-title":"BMC Gastroenterol"},{"issue":"suppl_3","key":"R100-20250504","first-page":"iii36","article-title":"Gastrointestinal complications: the most frequent internal complications of systemic sclerosis","volume":"48","author":"Forbes","year":"2006","journal-title":"Rheumatology"},{"key":"R101-20250504","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1002\/art.21261","article-title":"Prevalence of Barrett\u2019s esophagus in systemic sclerosis","volume":"52","author":"Wipff","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R102-20250504","doi-asserted-by":"crossref","first-page":"762546","DOI":"10.1155\/2015\/762546","article-title":"Gastric antral vascular ectasia in systemic sclerosis: current concepts","volume":"2015","author":"Parrado","year":"2015","journal-title":"Int J Rheumatol"},{"key":"R103-20250504","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nrgastro.2016.99","article-title":"Current management of the gastrointestinal complications of systemic sclerosis","volume":"13","author":"Emmanuel","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R104-20250504","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11926-011-0217-3","article-title":"Gastrointestinal manifestations of scleroderma: recent progress in evaluation, pathogenesis, and management","volume":"14","author":"Gyger","year":"2012","journal-title":"Curr Rheumatol Rep"},{"key":"R105-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00403-018-1874-0","article-title":"Small intestinal bacterial overgrowth in systemic sclerosis: a review of the literature","volume":"311","author":"Polkowska-Pruszynska","year":"2019","journal-title":"Arch Dermatol Res"},{"key":"R106-20250504","doi-asserted-by":"crossref","first-page":"651748","DOI":"10.3389\/fmed.2021.651748","article-title":"The PREdictor of MAlnutrition in systemic sclerosis (PREMASS) score: a combined index to predict 12 months onset of malnutrition in systemic sclerosis","volume":"8","author":"Bagnato","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R107-20250504","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/jpen.1872","article-title":"Assessing malnutrition in systemic sclerosis with global leadership initiative on malnutrition and european society of Clinical nutrition and metabolism criteria","volume":"45","author":"Rosato","year":"2021","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"R108-20250504","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1007\/s10067-020-05141-0","article-title":"Reduction of fat free mass index and phase angle is a risk factor for development digital ulcers in systemic sclerosis patients","volume":"39","author":"Rosato","year":"2020","journal-title":"Clin Rheumatol"},{"key":"R109-20250504","first-page":"65","article-title":"Advanced microvascular damage associated with occurence of sarcopenia in systemic sclerosis patients: results from a retrospective cohort study","volume":"38(","author":"Paolino","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"R110-20250504","doi-asserted-by":"crossref","first-page":"110730","DOI":"10.1016\/j.nut.2020.110730","article-title":"Phase angle could be a marker of microvascular damage in systemic sclerosis","volume":"73","author":"Gigante","year":"2020","journal-title":"Nutrition"},{"key":"R111-20250504","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.nut.2018.03.046","article-title":"Prevalence of sarcopenia in systemic sclerosis: assessing body composition and functional disability in patients with systemic sclerosis","volume":"55\u201356","author":"Siegert","year":"2018","journal-title":"Nutrition"},{"key":"R112-20250504","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s10067-017-3932-y","article-title":"Malnutrition and sarcopenia in a large cohort of patients with systemic sclerosis","volume":"37","author":"Caimmi","year":"2018","journal-title":"Clin Rheumatol"},{"key":"R113-20250504","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s10067-013-2235-1","article-title":"Risk factors for body composition abnormalities in systemic sclerosis","volume":"32","author":"Marighela","year":"2013","journal-title":"Clin Rheumatol"},{"issue":"10 Pt 2","key":"R114-20250504","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1016\/j.lpm.2014.03.029","article-title":"Gastrointestinal involvement in systemic sclerosis","volume":"43","author":"Savarino","year":"2014","journal-title":"Presse Med"},{"key":"R115-20250504","first-page":"42","article-title":"Systemic sclerosis: description and diagnostic role of the oral phenomena","volume":"52","author":"Scardina","year":"2004","journal-title":"Gen Dent"},{"key":"R116-20250504","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1159\/000490526","article-title":"Chronic intestinal pseudo-obstruction in systemic sclerosis: an uncommon presentation","volume":"12","author":"Shah","year":"2018","journal-title":"Case Rep Gastroenterol"},{"key":"R117-20250504","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.semarthrit.2006.08.002","article-title":"Esophageal involvement in scleroderma: gastroesophageal reflux, the common problem","volume":"36","author":"Ntoumazios","year":"2006","journal-title":"Semin Arthritis Rheum"},{"key":"R118-20250504","first-page":"FPL6","article-title":"[Systemic sclerosis \u2013 a rare but important diagnosis in primary health care]","volume":"116","author":"Andreasson","year":"2019","journal-title":"Lakartidningen"},{"key":"R119-20250504","first-page":"2047","article-title":"[Watermelon stomach and scleroderma]","volume":"164","author":"Diederichsen","year":"2002","journal-title":"Ugeskr Laeger"},{"key":"R120-20250504","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.14309\/ajg.0000000000000397","article-title":"Colonic manifestations and complications are relatively under-reported in systemic sclerosis: a systematic review","volume":"114","author":"Brandler","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"R121-20250504","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/BF02051176","article-title":"Anorectal dysfunction and rectal prolapse in progressive systemic sclerosis","volume":"36","author":"Leighton","year":"1993","journal-title":"Dis Colon Rectum"},{"key":"R122-20250504","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.semarthrit.2014.05.010","article-title":"Mortality and survival in systemic sclerosis: systematic review and meta-analysis","volume":"44","author":"Rubio-Rivas","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"R123-20250504","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.3899\/jrheum.090340","article-title":"Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients","volume":"36","author":"Assassi","year":"2009","journal-title":"J Rheumatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000031780","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T01:04:22Z","timestamp":1746320662000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000031780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,11]]},"references-count":119,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000031780","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,11]]}}}